GPR81 nuclear transportation is critical for cancer growth and progression in lung and other solid cancers
The interaction of GPR81 with SFPQ promotes cancer cell malignancy. GPR81 nuclear translocation is critical in conferring cancer progression and may be a potential therapeutic target for limiting cancer progression<b>.</b>
Authors
- Thomas J. Y. Kono (ORCID: https://orcid.org/0000-0002-1388-3194)
- Robert A. Kratzke (ORCID: https://orcid.org/0000-0002-1599-7494)
- Sabine Karam (ORCID: https://orcid.org/0000-0003-0989-0241)
- Bo Sun (ORCID: https://orcid.org/0000-0002-3620-4131)
- Craig A. Henke (ORCID: https://orcid.org/0000-0002-7484-1131)
- Adam Gilbertsen (ORCID: https://orcid.org/0000-0001-7998-912X)
- Libang Yang (ORCID: https://orcid.org/0000-0002-9318-6320)
- Scott M. Dehm (ORCID: https://orcid.org/0000-0002-7827-5579)
- Yingming Li (ORCID: https://orcid.org/0000-0003-4261-9744)
- Blake A. Jacobson
Institutions
- University of Minnesota (US)
- University of Minnesota System (US)
- University of Minnesota, Duluth (US)
- University of Minnesota Medical Center (US)
- Minnesota Oncology (US)
Publication Details
- Journal
- World Journal of Clinical Oncology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.5306/wjco.v16.i8.107208
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94